Navigation Links
Omeros Announces Initiation of Patient Enrollment in OMS201 Phase 1 Study
Date:5/20/2008

SEATTLE, May 20 /PRNewswire-FirstCall/ -- Omeros Corporation today announced that it has begun patient enrollment for the Phase 1 study of OMS201, the Company's second PharmacoSurgery(TM) drug product candidate, for use during urological surgery. At least 24 patients undergoing unilateral ureteroscopic removal of stones with a maximum diameter of 12 mm located in the renal-collecting system or ureter will be enrolled in the study.

"Advancing another PharmacoSurgery(TM) product candidate into clinical development marks an important milestone for Omeros," said Dr. Gregory A. Demopulos, Chairman and Chief Executive Officer of Omeros. "From our PharmacoSurgery(TM) platform, Omeros is developing a series of product candidates to improve clinical outcomes for surgical patients. The study for OMS201 expands our PharmacoSurgery(TM) platform into urological surgery."

OMS201 is one of the four clinical development programs in the Company's PharmacoSurgery(TM) platform. PharmacoSurgery(TM) product candidates are combinations of therapeutic agents designed to act simultaneously at multiple discrete targets to preemptively block the molecular-signaling and biochemical cascade caused by surgical trauma and to provide clinical benefits both during and after surgery. The lead product candidate in the PharmacoSurgery(TM) platform is OMS103HP, which is currently in two Phase 3 clinical programs evaluating OMS103HP's safety and ability to improve postoperative joint function and reduce pain following arthroscopic surgery.

The Phase 1 randomized, double-blind, vehicle-controlled and parallel-assigned study of OMS201 is designed to evaluate the systemic absorption and safety of OMS201 in patients receiving primary treatment by endoscopic removal of urinary stones. OMS201, developed from Omeros' proprietary PharmacoSurgery(TM) platform, is designed for use during urological surgery, including uroendoscopic procedures such as ureteroscopy, cystoscopy and minima
'/>"/>

SOURCE Omeros Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Fuisz Tobacco Announces Clinical Study Results for Fuisz Tobacco Sheet Strip; Super Enhanced Bioavailability of Nicotine From Its Tobacco Sheet Strip Supports Efficacy of Low Dose Tobacco Product
2. InterMune Announces Receipt of Fast Track Designation for Pirfenidone From FDA
3. Ipsogen Announces Three Studies at the American Society of Clinical Oncology (ASCO) Meeting Extending the Utility of the Genomic Grade Index for Predicting Response to Chemotherapy in Breast Cancer
4. TAP Pharmaceutical Products Inc. Announces Phase 3 TAK-390MR Data Demonstrating Higher Overall Healing Versus Lansoprazole in Patients with Erosive Esophagitis
5. Pulmo BioTech Announces Details of the Methodology for its Phase I Human Trials
6. GSK Announces Results of First Phase III Trial Evaluating Tykerb(R) (Lapatinib) Plus Herceptin(R) (Trastuzumab)
7. ADVENTRX Announces ANX-530 Safety Data From Registrational Bioequivalence Clinical Study
8. Medivation Announces Presentation of MDV3100 Clinical Data in Patients With Castration-Resistant Prostate Cancer at 44th American Society of Clinical Oncology Annual Meeting
9. BiPar Sciences Announces Clinical Data Presentations on Lead PARP Inhibitor, BSI-201, at 40th American Society of Clinical Oncology Annual Meeting
10. IDM Pharma Announces Updated Data From Mifamurtide (L-MTP-PE) Compassionate Access Program
11. Biopure Announces Publication of Phase II Proof-of-Concept Coronary Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... 21, 2014  eRelevance Corporation ( www.erelevancecorp.com ), ... that it has completed integration with Nextech, a ... Surgery and Dermatology practices. "Integration allows ... healthcare practices using Nextech," stated Bob Fabbio ... information from the EMR we are able to ...
(Date:8/21/2014)... , Aug. 21, 2014 /CNW/ - Eisai Limited is ... introduction of the first-of-its-kind comic book available in ... has been designed specifically to educate children and their parents ... Canada affecting more than 300,000 Canadians. Eisai is ... care (hhc) , in which the patient is central – ...
(Date:8/21/2014)... CHARLOTTE, N.C. , Aug. 21, 2014 /PRNewswire-iReach/ ... Home Medical Equipment, Inc. for the third straight ... annual Inc. 500|5000, an exclusive ranking of the ... most comprehensive look at the most important segment ... Yelp, Pandora, Timberland, Dell, Domino,s Pizza, LinkedIn, Zillow, ...
Breaking Medicine Technology:eRelevance Corporation Integrates with Nextech Electronic Medical Records 2Eisai Pleased to Support Canadian Epilepsy Alliance Comic Book that Teaches Children About Epilepsy 2Carolina's HME Named for Third Straight Year to Inc. Magazine's List of America's Fastest-Growing Private Companies--the Inc. 5000 2Carolina's HME Named for Third Straight Year to Inc. Magazine's List of America's Fastest-Growing Private Companies--the Inc. 5000 3
... important treatment option for more vulnerable populations , ... showed that pitavastatin is an effective treatment for the ... safety and tolerability profile to low-dose pravastatin. The ... the XV International Symposium on Atherosclerosis in Boston. , ...
... was found to be prevalent in cancer patients regardless of ... conducted at Cancer Treatment Centers of America ... screening for vitamin D deficiency and aggressive vitamin D repletion ... , (Logo: http://www.newscom.com/cgi-bin/prnh/20090612/CTCALOGO ) , ...
Cached Medicine Technology:Study Demonstrates Efficacy of Pitavastatin in Elderly Patients 2Study Demonstrates Efficacy of Pitavastatin in Elderly Patients 3Study Suggests Vitamin D Screening and Appropriate Supplementation Indicated for All Cancer Patients 2
(Date:8/22/2014)... growth factor receptor (EGFR) mutations found in the circulating ... non-small cell lung cancer (NSCLC) patients correlates well with ... EGFR tyrosine kinase inhibitor (TKI) therapy is approved for ... the standard for determining mutation status is with DNA ... or not available. A more abundant and less invasive ...
(Date:8/22/2014)... NV (PRWEB) August 22, 2014 ... Dr. Sen and Dr. Samantha Pearson to help people ... and avoid corrective vision surgery by instead improving their ... prompting an investigative review. , “There’s a reason ... dollars in revenue each year—it’s because people just assume ...
(Date:8/22/2014)... Chicago, IL (PRWEB) August 22, 2014 ... become a thriving fertility destination, and now offers the ... interdisciplinary team of infertility specialists. The fertility network of ... an overall commitment to world-class reproductive care, female and ... program lives up to the standards so eminently set ...
(Date:8/22/2014)... August 22, 2014 The improved access ... specifically in the developing world, has led to the ... number of deaths due to AIDS globally. However, despite ... number of new patients becoming affected by the virus ... being undertaken by all related organisations and stakeholders, by ...
(Date:8/22/2014)... August 22, 2014. A new study of ... with multiple sclerosis (MS) may be able to ... study was epublished ahead of print on July ... Genova, Hali Griswold, Nancy D. Chiaravalloti & John ... with multiple sclerosis doi: 10.3233/NRE-141113). Self-awareness is one,s ...
Breaking Medicine News(10 mins):Health News:High concordance between EGFR mutations from circulating-free tumor DNA and tumor tissue in non-small cell lung cancer 2Health News:Restore My Vision Today: Review Exposes Natural Eye Restoration Guide by Dr. Sen and Dr. Samantha Pearson 2Health News:Mexico Now Offers Top Program for Couples Suffering from Male Infertility 2Health News:Mexico Now Offers Top Program for Couples Suffering from Male Infertility 3Health News:Mexico Now Offers Top Program for Couples Suffering from Male Infertility 4Health News:Worldwide HIV Infection Drug Market Examined in New Kuick Research Report Published at MarketPublishers.com 2Health News:Worldwide HIV Infection Drug Market Examined in New Kuick Research Report Published at MarketPublishers.com 3Health News:Kessler Foundation study of self-awareness in MS has implications for rehabilitation 2
... Reinberg HealthDay Reporter , TUESDAY, Feb. 7 (HealthDay News) ... a new "universal" influenza vaccine: one that might be effective against ... year, as now happens. "Our hope is to develop a ... subtypes so we won,t need to keep making new flu vaccines ...
... Repeat cases of shingles may be more common than suspected, ... people only get shingles once in a lifetime. People ... severe pain. The condition is caused by the herpes zoster ... Minn., analyzed the medical records of nearly 1,700 patients, aged ...
... Wiley-Blackwell, the Scientific, Technical, Medical, and Scholarly (STMS) publishing ... 42 new titles to its journals program in 2011, ... collaboration with societies or other organizations. Beginning ... Wiley Online Library, offering the latest, peer-reviewed research in ...
... a new and unusual "app" for the smart phone: tracking air ... and preventive medicine, has received a grant to assess a person,s ... this case, the City of Buffalo. The study is ... Health (NIH). A city,s air pollution varies from downtown ...
... associated with higher risks of obesity, heart disease, diabetes, and ... In a ground-breaking new study published in the Feb. ... from University Hospitals (UH) Case Medical Center and Case Western ... less than six hours of sleep at night had an ...
... Mich. Without fanfare, hundreds of thousands of children ... usually to alleviate recurring infections and obstructive sleep problems. ... to a pathologist, who looks for evidence of more ... common practice may not be cost-effective because those additional ...
Cached Medicine News:Health News:'Universal' Flu Vaccine Shows Promise in Early Trial 2Health News:'Universal' Flu Vaccine Shows Promise in Early Trial 3Health News:Shingles Returns More Often Than Thought 2Health News:Over 40 new titles added to Wiley-Blackwell's journals program in 2011 2Health News:New study to use smart phones to track air pollution exposure 2Health News:Lack of sleep found to be a new risk factor for colon cancer 2Health News:The great tonsil dilemma 2Health News:The great tonsil dilemma 3
Solid 4 mm blades. Locking thumb. Dull finish. Holes in bar decrease weight of speculum....
Open 14 mm blades with 6 mm lifting wings. Dull finish....
Open 10 mm blades. Dull finish....
Open wire style 16 mm blade with a wing tip twist giving the surgeon better on-axis accessibility....
Medicine Products: